Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Medicines shortages

HRT shortages prompts guidance on availability

Shortages of hormone replacement therapy (HRT) have prompted the British Menopause Society (BMS) to issue guidance on the supplies that are currently available.

Following reports of up to half of HRT products being out of stock, the update on product availability is intended for BMS members, clinicians and patients who may be experiencing difficulties in obtaining HRT supplies.

Haitham Hamoda, chair of the BMS, said there had been “availability issues with many HRT products”.

“Some of these are related to manufacturing shortages, while others are related to supply issues. The BMS has been reassured that these are temporary shortages which pharmaceutical companies and their suppliers are trying to resolve,” he added.

Information on stock availability and supplies was obtained by the BMS from the manufacturers of HRT products.

The products in short supply include Evorel patches, manufactured by Janssen, and some HRT products manufactured by Mylan.

Hamoda said prescribers dealing with shortages “can consider equivalent preparations that provide a similar dose to what their patient is using”.

“If an exact match is not possible, prescribers can seek guidance available on the practical prescribing chart on the BMS website and Menopause Matters website to clarify equivalent doses,” he added.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206936

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.